Search

Search Constraints

You searched for: Author/Creator Ortega Granados, Ana Laura

Search Results

1. 362 A PhII study of bemcentinib, a first-in-class selective AXL kinase inhibitor, in combination with pembrolizumab in pts with previously-treated advanced NSCLC: Updated clinical & translational analysis. (9th November 2020)

2. 362 A PhII study of bemcentinib, a first-in-class selective AXL kinase inhibitor, in combination with pembrolizumab in pts with previously-treated advanced NSCLC: Updated clinical & translational analysis. (9th November 2020)

3. Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study). (November 2022)

4. Lung cancer symptoms at diagnosis: results of a nationwide registry study. Issue 6 (19th November 2020)

5. Lung cancer symptoms at diagnosis: results of a nationwide registry study. Issue 6 (19th November 2020)

6. Lung cancer symptoms at diagnosis: results of a nationwide registry study. Issue 6 (19th November 2020)

7. Lung cancer symptoms at diagnosis: results of a nationwide registry study. Issue 6 (19th November 2020)

8. Lung cancer symptoms at diagnosis: results of a nationwide registry study. Issue 6 (19th November 2020)

9. Lung cancer symptoms at diagnosis: results of a nationwide registry study. Issue 6 (19th November 2020)

10. Lung cancer symptoms at diagnosis: results of a nationwide registry study. Issue 6 (19th November 2020)